PRKN

Chr 6AR

parkin RBR E3 ubiquitin protein ligase

Also known as: AR-JP, LPRS2, PARK2, PDJ

The encoded protein functions as an E3 ubiquitin ligase that targets substrate proteins for degradation and plays a critical role in mitochondrial quality control by removing damaged mitochondria through mitophagy. Mutations cause autosomal recessive juvenile-onset Parkinson disease, typically presenting in childhood or adolescence with movement disorders. This gene shows very low constraint against loss-of-function variants (pLI near zero), consistent with its recessive inheritance pattern where single gene copies are typically sufficient for normal function.

OMIMResearchSummary from RefSeq, OMIM, UniProt
ARLOEUF 0.863 OMIM phenotypes
Clinical SummaryPRKN
🧬
Gene-Disease Validity (ClinGen)
Parkinson disease · ARDefinitive

Definitive — sufficient evidence for diagnostic panels

Population Constraint (gnomAD)
Low constraint (pLI 0.00) — loss-of-function variants are relatively tolerated in the population.
💊
Clinical Trials
2 active or recruiting trials — potential therapeutic options may be available

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Tolerant — LoF & missense variants common in population
LoF Constraint
0.86LOEUF
pLI 0.000
Z-score 2.10
OE 0.55 (0.360.86)
Tolerant

Typical tolerance to LoF variation

Missense Constraint
-0.86Z-score
OE missense 1.15 (1.041.26)
310 obs / 270.1 exp
Tolerant

Tolerant to missense variation

Observed / Expected Ratios
LoF OE0.55 (0.360.86)
00.351.4
Missense OE1.15 (1.041.26)
00.61.4
Synonymous OE1.15
01.21.6
LoF obs/exp: 14 / 25.4Missense obs/exp: 310 / 270.1Syn Z: -1.23

ClinVar Variant Classifications

0 submitted variants in ClinVar

Protein Context — Lollipop Plot

PRKN · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

3D Protein StructureAlphaFold
Clinical Literature
Open Research Assistant →